Silencing Xeroderma Pigmentosum Group C Protein Mediates through Augmentation of Oxidative Stress to Sensitize Human Glioblastoma U87 Cells to Arsenic Trioxide
碩士 === 國立陽明大學 === 生物藥學研究所 === 97 === Arsenic trioxde (ATO) has been approved as an effective drug against acute promyelocytic leukemia (APL). The therapeutic application of ATO toward other cancers, including solid tumors, is potentially promising, but still limited. Numerous studies have shown that...
Main Authors: | Ching-Ya Wen, 溫晴雅 |
---|---|
Other Authors: | Te-Chang Lee |
Format: | Others |
Language: | zh-TW |
Published: |
2009
|
Online Access: | http://ndltd.ncl.edu.tw/handle/82q6sw |
Similar Items
-
Sestrin 2 (SESN2) or Xeroderma Pigmentosum Group C (XPC) Silencing Enhances Oxidative Damage in Glioblastoma Multiforme U87 Cells
by: Shin-Yi Liu, et al.
Published: (2010) -
Xeroderma pigmentosum
by: Lehmann Alan R, et al.
Published: (2011-11-01) -
Xeroderma Pigmentosum
by: Dogra Alka, et al.
Published: (2002-01-01) -
Camouflage in xeroderma pigmentosum
by: Gayathri Krishnaswamy, et al.
Published: (2016-01-01) -
Symptoms and Course of Xeroderma Pigmentosum
by: J Gordon Millichap
Published: (2008-08-01)